Deva Holding A.S. (IST:DEVA)

Market Cap	14.12B +3.6%
Revenue (ttm)	14.59B -25.8%
Net Income	300.30M -93.7%
EPS	1.50 -93.7%
Shares Out	200.02M
PE Ratio	47.02
Forward PE	n/a
Dividend	0.29 (0.41%)
Ex-Dividend Date	n/a

Volume	82,194
Average Volume	1,037,223
Open	70.65
Previous Close	70.60
Day's Range	70.65 - 71.30
52-Week Range	51.00 - 81.75
Beta	-0.50
RSI	44.28
Earnings Date	Mar 6, 2026

About Deva Holding A.S.

Deva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey. The company offers antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also provides products in the areas of urogenital system and sex hormones, blood and blood forming organs, cardiovascular system, musculoskeletal system, nervous system, alimentary tract and metabolism, respiratory system, urinary syste...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1958
• Employees: 3,036
• Stock Exchange: Istanbul Stock Exchange
• Ticker Symbol: DEVA

Financial Performance

In 2024, Deva Holding A.S.'s revenue was 15.46 billion, a decrease of -5.50% compared to the previous year's 16.36 billion. Earnings were 69.42 million, a decrease of -98.58%.